- Exchange: Toronto
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Isotechnika Pharma Inc
+ Add to WatchlistISA:CN
0.0350 CAD 0.00000.00%As of 15:58:09 ET on 05/17/2013.
Snapshot for Isotechnika Pharma Inc (ISA)
| Open: | - | Day's Range: | - | Volume: | 17,200 |
|---|---|---|---|---|---|
| Previous Close: | 0.0350 | 52wk Range: | 0.0250 - 0.1300 | 1-Yr Rtn: | -53.33% |
Key Statistics for ISA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPTSX | - |
| Earnings Per Share (ttm) | -0.0500 |
| Est. EPS (12/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M CAD) | 6.75 |
| Shares Outstanding (M) | 192.87 |
| 30 Day Average Volume | 127,084 |
| Price/Book (mrq) | 2.8013 |
| Price/Sale (ttm) | 15.4280 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/14/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ISA
Company Profile & Key Executives for ISA
Isotechnika Pharma Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of immunosuppressive therapeutics.
| Robert FosterPresident/CEO | Dennis BourgeaultChief Financial Officer |
| Launa AspesletChief Operating Officer | Derrick FreitagChief Scientific Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ISA News
-
Industry News
No stories found
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page